Based on the key indicators related to Medpace Holdings' liquidity, profitability, solvency, and operating efficiency, Medpace Holdings is performing exceptionally good at this time. It has a great probability to report excellent financial results in April. At this time, Medpace Holdings' Cash And Short Term Investments are relatively stable compared to the past year. As of 03/21/2025, Common Stock Total Equity is likely to grow to about 279.2 K, while Total Stockholder Equity is likely to drop slightly above 677.5 M. Key indicators impacting Medpace Holdings' financial strength include:
The financial analysis of Medpace Holdings is a critical element in measuring its lifeblood. Investors should not minimize Medpace Holdings' ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Medpace Holdings competes with IQVIA Holdings, Neogen, ICON PLC, Qiagen NV, and Waters. Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company was founded in 1992 and is based in Cincinnati, Ohio. Medpace Holdings operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 5000 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
The reason investors look at the income statement is to determine what Medpace Holdings' earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Medpace Holdings's current stock value. Our valuation model uses many indicators to compare Medpace Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medpace Holdings competition to find correlations between indicators driving Medpace Holdings's intrinsic value. More Info.
Medpace Holdings is considered to be number one stock in return on equity category among its peers. It is regarded third in return on asset category among its peers reporting about 0.25 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medpace Holdings is roughly 3.93 . At this time, Medpace Holdings' Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Medpace Holdings by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Medpace Holdings Systematic Risk
Medpace Holdings' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Medpace Holdings volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Medpace Holdings correlated with the market. If Beta is less than 0 Medpace Holdings generally moves in the opposite direction as compared to the market. If Medpace Holdings Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Medpace Holdings is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Medpace Holdings is generally in the same direction as the market. If Beta > 1 Medpace Holdings moves generally in the same direction as, but more than the movement of the benchmark.
Medpace Holdings Thematic Clasifications
Medpace Holdings is part of Business Services investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Business Services industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Business Services industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in Medpace Holdings Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Medpace Holdings' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Medpace Holdings growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Medpace Holdings help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medpace Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medpace Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Medpace Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medpace Holdings's daily price indicators and compare them against related drivers.
When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.